STAT Plus: Storm clouds gather over pharma companies as price hikes ease
JOSEPH EID/AFP/GETTY IMAGES
The loss of the ability to boost earnings through annual price increases, which has benefitted drug companies for years, is starting to take a toll.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario